[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PE11499A1 - TREATMENT OF HIV AND CANCER - Google Patents

TREATMENT OF HIV AND CANCER

Info

Publication number
PE11499A1
PE11499A1 PE1997000894A PE00089497A PE11499A1 PE 11499 A1 PE11499 A1 PE 11499A1 PE 1997000894 A PE1997000894 A PE 1997000894A PE 00089497 A PE00089497 A PE 00089497A PE 11499 A1 PE11499 A1 PE 11499A1
Authority
PE
Peru
Prior art keywords
cancer
agent
agents
dipinomycin
herbicide
Prior art date
Application number
PE1997000894A
Other languages
Spanish (es)
Inventor
James Berger Camden
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PE11499A1 publication Critical patent/PE11499A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE REFIERE AL USO DE ANTIFUNGICOS Y HERBICIDAS JUNTO CON REFORZADORES Y/O AGENTES ANTIVIRALES Y/O AGENTES QUIMIOTERAPEUTICOS, EN EL TRATAMIENTO DE LAS INFECCIONES VIRALES, COMO HIV, Y CANCER; EN DONDE: EL ANTIFUNGICO ES UN DERIVADO DE BENCIMIDAZOL, TIABENCIMIDAZOL, 1H-1,2,4-TRIAZOL, 1,3-BIS-TRIAZOLIL-2-PROPANOL, GRISEOFULVINA, DE PREFERENCIA DICHO FUNGICIDA ES TIABENDAZOL; EL HERBICIDA ES UN DERIVADO DE N-CLOROFENILCARBAMATO Y N-CLOROFENILTIOCARBAMATO, N-FOSFONOGLICINA, DE PREFERENCIA DICHO HERBICIDA ES CLOROPROFAN; EL REFORZADOR ES EL ACIDO 1-H-BENCIMIDAZOL-2-PROPANOICO (PROCODAZOL), ENTRE OTROS; EL AGENTE ANTIVIRAL ES AZT o 3TC; EL AGENTE QUIMIOTERAPEUTICO ES UN AGENTE INTERACTIVO DEL DNA, AGENTE INTERACTIVO DE TUBULINA o ANTIMETABOLITO COMO: ASPARAGINASA, HIDROXIUREA, CISPLATIN, CICLOFOSFAMIDA, ALTRETAMINA, BLEOMICIN, DACTINOMICIN, DOXORUBICIN, ETOPOSIDO, TENIPOSIDO, PLICAMICIN o TAXOL. LOS AGENTES HERBICIDAS SON EFECTIVOS CUANDO EL CANCER O VIRUS ES UNA CELULA ANIMAL GENETICAMENTE ALTERADA Y LOS AGENTE FUNGICIDAS SON EFECTIVOS CUANDO EL CANCER O VIRUS ES UNA CELULA ANIMAL QUE CONTIENE MATERIALES GENETICOS DERIVADOS DE HONGOS O MOHOSREFERS TO THE USE OF ANTIFUNGALS AND HERBICIDES TOGETHER WITH REINFORCEMENTS AND / OR ANTIVIRAL AGENTS AND / OR CHEMOTHERAPEUTIC AGENTS, IN THE TREATMENT OF VIRAL INFECTIONS, LIKE HIV, AND CANCER; WHERE: THE ANTIFUNGAL IS A DERIVATIVE OF BENZMIDAZOLE, TIABENCIMIDAZOLE, 1H-1,2,4-TRIAZOL, 1,3-BIS-TRIAZOLIL-2-PROPANOL, GRISEOFULVINE, OF PREFERENCE SAID FUNGICIDE IS TIABENDAZOLE; THE HERBICIDE IS A DERIVATIVE OF N-CHLOROPHENYL CARBAMATE AND N-CHLOROPHENYLTIOCARBAMATE, N-PHOSPHONOGLYCIN, PREFERRED SAID HERBICIDE IS CHLOROPROFAN; THE REINFORCER IS THE ACID 1-H-BENCIMIDAZOLE-2-PROPANOIC (PROCODAZOLE), AMONG OTHERS; THE ANTIVIRAL AGENT IS AZT or 3TC; CHEMOTHERAPEUTIC AGENT IS AN INTERACTIVE DNA AGENT, INTERACTIVE AGENT OF TUBULIN or ANTIMETABOLITE LIKE: ASPARAGINASE, HYDROXYUREA, CISPLATIN, CYTLOPHAMIDE, BLEOMYCIN, DIPINOMYCIN, DIPINOMYCIN, DOXORINE HERBICIDAL AGENTS ARE EFFECTIVE WHEN CANCER OR VIRUSES ARE A GENETICALLY ALTERED ANIMAL CELL AND FUNGICIDAL AGENTS ARE EFFECTIVE WHEN CANCER OR VIRUSES ARE AN ANIMAL CELL CONTAINING GENETIC MATERIALS DERIVED FROM FUNGI OR MOHOS

PE1997000894A 1997-05-16 1997-10-09 TREATMENT OF HIV AND CANCER PE11499A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4672697P 1997-05-16 1997-05-16

Publications (1)

Publication Number Publication Date
PE11499A1 true PE11499A1 (en) 1999-03-01

Family

ID=21945046

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1997000894A PE11499A1 (en) 1997-05-16 1997-10-09 TREATMENT OF HIV AND CANCER

Country Status (19)

Country Link
EP (1) EP0954309A1 (en)
JP (1) JP2000510156A (en)
KR (1) KR20000049064A (en)
CN (1) CN1254281A (en)
AR (1) AR009968A1 (en)
AU (1) AU7402998A (en)
BR (1) BR9712981A (en)
CA (1) CA2268848A1 (en)
CO (1) CO5070657A1 (en)
CZ (1) CZ124999A3 (en)
HU (1) HUP9904092A3 (en)
IL (1) IL129351A0 (en)
NO (1) NO991701L (en)
PE (1) PE11499A1 (en)
PL (1) PL335160A1 (en)
SK (1) SK46999A3 (en)
TR (1) TR199901530T2 (en)
WO (1) WO1998051303A1 (en)
ZA (1) ZA979095B (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) * 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
EP1154779A2 (en) * 1999-02-26 2001-11-21 Napro Biotherapeutics, Inc. Treatment regimen for prostate cancer, initiated after androgen ablative therapy has started
JP2002537328A (en) * 1999-02-26 2002-11-05 ナプロ バイオセラピューティクス，インコーポレイテッド Treatment regimen for hormone-sensitive cancer
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
WO2002015912A1 (en) * 2000-08-25 2002-02-28 Beth Israel Deaconess Medical Center Compounds and methods for inhibiting neuronal cell death
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) * 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
EP1330441A2 (en) * 2000-09-26 2003-07-30 The University of Arizona Foundation Benzimidazoles and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
WO2002041891A2 (en) * 2000-11-01 2002-05-30 The Procter & Gamble Company Hiv treatment with benzimidazoles
JP2004115397A (en) * 2002-09-25 2004-04-15 Fuji Photo Film Co Ltd Liposome comprising therapeutic agent for vascular disease
CN101111248A (en) * 2004-12-06 2008-01-23 新南部创新有限公司 Treatment for cancer
AU2005313839B2 (en) * 2004-12-06 2010-03-11 Pitney Pharmaceuticals Pty Limited Treatment for cancer
US7727967B2 (en) * 2006-02-24 2010-06-01 Boise State University Cyanooxime inhibitors of carbonyl reductase and methods of using said inhibitors in treatments involving anthracyclines
WO2009043093A1 (en) * 2007-10-04 2009-04-09 Newsouth Innovations Pty Limited Hif inhibition
CN101643729B (en) * 2008-08-07 2011-12-28 复旦大学 Nucleic acid molecule NRN1SR22 and application thereof in preparation of anticancer medicaments
US10435365B2 (en) 2014-03-16 2019-10-08 Hadasit Medical Research Services And Development Ltd. Type III deiodinase inhibitors and uses thereof
CN105418711A (en) * 2015-11-06 2016-03-23 山东大学 Application of alpha-L-rhamnosidase to preparing hydroxycarbamide and glycoside derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2139052C1 (en) * 1993-03-31 1999-10-10 Мерк Энд Ко., Инк. Combination of hiv-protease inhibitor with other antiviral compounds, pharmaceutical composition based on said and method of pharmaceutical composition preparing
CA2217953C (en) * 1995-04-12 2001-12-04 The Procter & Gamble Company A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers
US5665713A (en) * 1995-04-12 1997-09-09 Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US5656615A (en) * 1995-04-12 1997-08-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers and viruses in mammals
NZ315184A (en) * 1995-08-04 2000-05-26 Procter & Gamble Use of fluconazole for inhibiting the growth of cancers and viral infections

Also Published As

Publication number Publication date
JP2000510156A (en) 2000-08-08
NO991701L (en) 2000-01-17
CN1254281A (en) 2000-05-24
PL335160A1 (en) 2000-04-10
HUP9904092A2 (en) 2000-04-28
NO991701D0 (en) 1999-04-09
IL129351A0 (en) 2000-02-17
CA2268848A1 (en) 1998-11-19
WO1998051303A1 (en) 1998-11-19
EP0954309A1 (en) 1999-11-10
ZA979095B (en) 1998-05-11
CZ124999A3 (en) 1999-09-15
TR199901530T2 (en) 1999-10-21
AR009968A1 (en) 2000-05-17
CO5070657A1 (en) 2001-08-28
SK46999A3 (en) 2000-05-16
BR9712981A (en) 2000-04-18
AU7402998A (en) 1998-12-08
HUP9904092A3 (en) 2000-07-28
KR20000049064A (en) 2000-07-25

Similar Documents

Publication Publication Date Title
PE11499A1 (en) TREATMENT OF HIV AND CANCER
ES2178720T3 (en) SYNERGIC HERBICIDE BLENDS.
BR9911125B1 (en) Synergistic insecticide and fungicide composition for the fight against plant pests, their preparation and use processes, as well as the process for the fight against fungi and insects.
DE59207399D1 (en) Microbicidal drug combinations
CU22867A3 (en) HERBICIDAL COMPOSITION
DK0533017T3 (en) Water-based, solvent- and emulsifier-free microbicidal combinations of active substances
ITMI931025A0 (en) HERBICIDES FOR THE FIGHT AGAINST WEEDS IN RICE CROPS
ATE24909T1 (en) ANTIFUNGAL TRIAZOLES.
DE59204120D1 (en) Water-based, solvent and emulsifier-free combination of microbicides.
IL98153A0 (en) Agent for preserving wood or wood-based materials containing at least one fungicide and/or at least one insecticide
ATE231687T1 (en) NEW COMPOUND ACTIVE AGAINST DIPTERA AND BACILLUS THURINGIENSIS STRAINS
ITMI932282A1 (en) HERBICIDES FOR THE FIGHT AGAINST PESTS IN RICE CULTIVATIONS
DK164888C (en) SYNERGISTIC FUNGICIDE AGENT, APPLICATION OF THE AGENT AND A PROCEDURE FOR COMBATING FUNGI
MX9304456A (en) STABLE PESTICIDE COMPOSITIONS IN STORAGE INCLUDING AZADIRACTIN AND EPOXIDE.
ATE260559T1 (en) SORDARINE DERIVATIVES
Gibbons Asian gypsy moth jumps ship to United States
ES2185051T3 (en) INSECTICIDES AND ACARICIDES COMPOSITIONS.
RU98100272A (en) FUNGICIDAL COMBINATION OF ACTIVE SUBSTANCES
AR002150A1 (en) FUNGICIDE COMPOSITIONS CONTAINING 8-T-BUTYL-2- (N-ETHYL-NN-PROPYLAMINE) -METHYL-1,4-DIOXAESPIRE [5,4] DECANE, TEBUCONAZOLE AND PROPICONAZOLE, PROCEDURE FOR THE OBTAINING OF SUCH COMPOSITIONS AND PROCEDURES FIGHT AGAINST FUNGI.
BG104259A (en) Derivatives of 4-cyano-4-deformylsordaricin
GR880100229A (en) Presticides and their use in reducing insect infestations in plants containing tannins
Winder et al. Terminology in microbial control of weeds
GB809708A (en) Improvements in or relating to biologically active compositions
Cunningham et al. Orgyia pseudotsugata(McDunnough), Douglas-fir tussock moth(Lepidoptera: Lymantriidae).
Sherris Skin and wound infections.

Legal Events

Date Code Title Description
FC Refusal